The Weekly Recap 8/21/26: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni receive new funding, achieve regulatory approvals, appoint new executives, and much more on the road to LSI Europe ‘26 in Barcelona (September 28 - October 1).

ANEUVO

Announced a new strategic relationship with MellingMedical to bring the company's advanced technologies to federal healthcare providers serving America’s veterans, active-duty military personnel, and their families. The collaboration makes the ExaStim^® Stimulation System immediately available to veterans through MellingMedical’s federal contracting network. 

Aptitude Medical Systems

Appointed JP (Jinpeng) Wang as Co-CEO to lead the company alongside LSI Alumni Scott Ferguson. Wang co-founded the company with Ferguson and Qiang (Jackson) Gong in 2011 and has been instrumental in shaping the company's strategy, vision, and culture.

Avania

Welcomed Francis Duhay, MD, as its first-ever Chief Medical Officer. A cardiothoracic surgeon and former Edwards Lifesciences CMO, Dr. Duhay led the development of the SAPIEN transcatheter heart valve and has guided more than 90 clinical studies.

BMI OrganBank

Welcomed three new investors, including Sand Hill Angels, Robin Hood Ventures, and New York Angels, along with a follow-on investment from Wexford Science & Technology Venture Fund. The funding will support continued development of the company’s kidney preservation technology, designed to give transplant teams more time and physiologic data from recovery through transport.

eCential Robotics

Received FDA clearance for its Op.n™ Spine Navigation and Robotics Guidance Platform. Built upon a modular architecture, the platform offers surgical navigation, robotics, and 2D/3D intraoperative imaging solutions, either combined or as stand-alone solutions.

Epitel & Stratus

Announced a strategic distribution agreement to add Epitel's wireless REMI™ Remote EEG Monitoring System to Stratus' portfolio, allowing the nation's leading EEG services provider to broaden patient access to critical EEG services nationwide. REMI is designed to support patients in various settings and across an array of EEG needs, including patients with infrequent seizures, certain rural and underserved communities, patients for whom a full 10-20 video EEG setup is impractical, and care settings where staffing or logistical constraints have historically limited access to monitoring.

Masimo

Received CE Mark approval for smartSedLine, its next-generation brain function monitor designed to improve intraoperative anesthesia management. The key innovation is an AI-powered Patient State Index (PSi) algorithm, which continuously processes bilateral frontal EEG data and translates complex brain activity into a 0-to-100 sedation index.

MaxQ Medical

Closed a $31.5M Series A financing round to grow the team and advance the company's clinical program. The round was led by Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, with strong participation from existing investor Hillside Capital.

Nanochon

Received regulatory approval from Panamá's Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients with focal chondral defects of the knee and represents a major milestone in the company's clinical and regulatory development strategy.

Onera Health

Received EU MDR Quality Management certification. This certification ensures continued access to the next generation of the company’s sleep testing products for patients in Europe.

Renata Medical

Closed a $25M Series D financing round led by ARCHIMED, with participation from existing investors. The funding will support expanded U.S. commercialization of the Minima™ Stent System, international market entry, development of pediatric-specific congenital heart disease technology, and continued clinical evidence generation.

SURGERIX

Closed a €900K funding round to accelerate preclinical research and regulatory preparation for its innovative microsurgery platform, with backing from early-stage venture funds, angel investors, and Business Finland’s Industrial Research funding program. Participating private investors included experienced angels such as Kustaa Piha of Athensmed, Leena Niemistö of Kaikarhenni, and Innovestor Angel CoFund.

UNC Health Ventures

Announced the rebranding of Rex Health Ventures and the launch of UNC Health Ventures, its corporate venture capital and strategic investment platform. The platform builds on more than a decade of investment experience and will help UNC Health partner with emerging healthcare companies that support better care, stronger operations, improved patient experience, and long-term value creation.

Vitestro

Received FDA De Novo authorization for Aletta^®, its Autonomous Robotic Phlebotomy Device™, designed to autonomously perform diagnostic blood collection. The system combines multimodal imaging, robotics, and artificial intelligence to identify veins, guide needle insertion, and collect blood samples with precision and consistency, supporting phlebotomy departments while addressing staffing challenges and standardizing care.

Wellvii

Received FDA clearance for its BP Go blood pressure monitor. The device uses a finger-based sensor to measure blood pressure rather than the traditional inflatable arm cuff and is designed for home and remote-care monitoring settings.

XEOS

Welcomed Suzanne Winter to its Board of Directors, bringing more than 35 years of experience across medtech, diagnostics, and digital health. Winter previously served as President and CEO of Accuray and held senior leadership roles at Medtronic and GE Healthcare, with extensive experience leading global commercial teams from both startup and corporate perspectives.

Stay tuned for more updates, insights, and achievements of our LSI Alumni in The Weekly Recap, and follow our blog for the latest medical device news and advancements.